InsidersTradesSigma
Browse the detailed record of transactions filed by Petter Segelman Lindqvist, 董事长兼首席执行官. Officer active across 2 companies, notably Isofol Medical AB (publ). Cumulatively, 2 disclosures have been logged. Activity tracked since 19 June 2025. The latest transaction was filed on 2 July 2025 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Petter Segelman Lindqvist is the CEO of Isofol Medical AB (publ), an innovative company in the biotechnology sector. Under his leadership, Isofol Medical focuses on developing innovative treatments for cancer. Petter brings extensive experience in management and product development, enabling him to guide the company to new heights. His commitment to innovation and research is essential for Isofol Medical's success.